Abstract:Background: Drug-induced liver injury (DILI) is a complex disease and could lead to death.The clinical characteristics of DILI vary in China and western countries.This study analyzed the causes, clinical features and outcomes of DILI from China.Methods: All 2035 cases with DILI were retrospectively collected from the 96857 hospitalized patients due to liver injury in the 302 Military Hospital between January 2009 and January 2014.Results: Chinese herbal medicine (CHM) was implicated in 595 patients (29.2%), whereas Western medicine (WM) and a combination of WM and CHM were implicated in 875 cases (43.0%) and the other patients (27.8%), respectively.The major classes of implicated WM were antibiotics and antituberculotics and the most commonly implicated antibiotic was azithromycin.In patients with DILI caused by CHM, 52.4% were caused by herbal decoction and the major implicated herb were Polygonum multiflorum.Compared to WM, there were more female patients, less alcohol use, and higher proportion of hepatocellular injury pattern in cases with caused by CHM, but no differences in outcomes was found.The outcomes of the entire DILI cases were generally good, whereas 345 cases got poor prognosis, in which 13.3% developed into chronic DILI, 3.1% died due to liver injury, and 0.5% underwent liver transplantation.A model for prediction about prognosis of DILI, involving alanine transaminase (ALT), alkaline phosphatase (ALP), total bilirubin (TB) and international normalized ratio ( INR), was established and achieved sensitivity and specificity both over 0.90.Conclusions: The clinical characteristics of DILI in China are different from those in western countries and the features of cases with DILI caused by CHM differ from those by WM.The established prognosis model was ready-to-use to give prediction of outcome by biochemical indices.Table 1.Characteristics of patients with DILI caused by Chinese herbal medicine as compared with Western medicine.* The patients who had drinking history did not drink within the latest month before liver injury.Δ Except for 1 case caused by Chinese herbal medicine dying from primary disease (restrictive cardiomyopathy).For identifying predictors of outcome, the patients who had developed into chronic DILI, died, and undergone liver transplantation were combined into the poor prognosis group and compared with the good prognosis group consisting of the healed cases.

A review of herb-induced liver injury in mainland china

[Analysis of Clinical Characteristics in 595 Patients with Herb-induced Liver Injury].

Herbal and dietary supplement-induced liver injury in Taiwan: comparison with conventional drug-induced liver injury

Herbal hepatotoxicity in traditional and modern medicine: actual key issues and new encouraging steps

A Network-Based Pharmacology Study of the Herb-Induced Liver Injury Potential of Traditional Hepatoprotective Chinese Herbal Medicines

Herbal and dietary supplement induced liver injury: Highlights from the recent literature

[Guidelines for Clinical Diagnosis and Treatment of Herb-Induced Liver Injury].

Traditional Chinese Medicine and herbal hepatotoxicity: a tabular compilation of reported cases

Literature Review of Traditional Chinese Medicine Herbs–Induced Liver Injury From an Oncological Perspective With RUCAM

Hepatobiliary and pancreatic: Comparison between Chinese herbal medicine and Western medicine-induced liver injury of 1985 patients.

Integrated evidence chain-based identification of Chinese herbal medicine-induced hepatotoxicity and rational usage: Exemplification by Polygonum Multiflorum (He shou wu)

Herbal and Dietary Supplement-Induced Liver Injury: A Nationwide Comparative Study

Systematic review on herb-induced liver injury in Korea

Herb induced liver injury by Xianling Gubao Tablets: A case assessed for causality using updated RUCAM and integrated evidence chain

Traditional Chinese Medicine (TCM) and Herbal Hepatotoxicity: RUCAM and the Role of Novel Diagnostic Biomarkers Such as MicroRNAs

Insights gained into the injury mechanism of drug and herb induced liver injury in the hepatic microenvironment

A new prognostic model for drug-induced liver injury especially suitable for Chinese population

Progress in research on the pathogenesis of immune regulation and idiosyncratic drug-induced liver injury

Successful corticosteroid therapy for severe liver injury secondary to herbal traditional Chinese medicine, Mega Defends X, assessed for causality by the updated RUCAM: A case report

Causes, Clinical Features, and Outcomes in 2035 Patients With Drug-Induced Liver Injury From China: Comparison Between Chinese Herbal Medicine and Western Medicine

Herbal medicines: challenges in the modern world. Part 3. China and Japan